Currently submitted to: Journal of Medical Internet Research
Date Submitted: Feb 14, 2026
Open Peer Review Period: Feb 15, 2026 - Apr 12, 2026
(closed for review but you can still tweet)
NOTE: This is an unreviewed Preprint
Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).
Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.
Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.
Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.
Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
The Effectiveness of Digital Intelligence Interventions for Depression and Anxiety: A Systematic Review and Meta-Analysis
ABSTRACT
Background:
Depression and anxiety are common mental disorders across all age groups. Digital intelligent interventions have not only overcome the time and space limitations of traditional psychotherapy but also provided innovative pathways for treating these conditions. However, the specific effectiveness of such interventions among groups with different demographic characteristics remains to be further clarified.
Objective:
To evaluate the effectiveness of digital intelligence interventions on symptoms of depression and anxiety using meta-analytic methods
Methods:
We searched the PubMed, Embase, Cochrane Library, Web of Science, and BIOSIS databases from inception through June 2025 for randomized controlled trials (RCTs) of digital interventions targeting depression or anxiety. Two reviewers independently screened the studies, extracted the data, and assessed the risk of bias using the Cochrane Risk of Bias tool. Meta-analyses were performed using RevMan 5.4 and Stata 15.0. Standardized mean differences (SMDs) with 95% confidence intervals (CIs) were used to assess continuous outcomes. Heterogeneity and subgroup analyses were performed.
Results:
Nineteen RCTs involving 4,679 participants were included. Compared with controls, digital interventions significantly reduced depressive symptoms (SMD = −0.25; 95% CI, −0.41 to −0.09; P = .002) and anxiety symptoms (SMD = −0.20; 95% CI, −0.32 to −0.08; P = .0009). Subgroup analysis by intervention duration indicated the largest effect for depressive symptoms at approximately 4 weeks (SMD = −0.26; 95% CI, −0.40 to −0.11; P = .0006). The greatest reduction in anxiety symptoms was observed at 5–8 weeks (SMD = −0.22; 95% CI, −0.47 to 0.03; P = .08), though this did not reach statistical significance.App-based interventions demonstrated the most significant effects on depression and anxiety, with effect sizes of (SMD=-0.44 (95% CI: -0.82, -0.06; P = .02) ;SMD= -0.36 (95% CI: -0.59, -0.12; P = .003), respectively. Furthermore, therapeutic efficacy was superior among the older adult population, showing values of SMD= -0.37 (95% CI: -0.64, -0.09; P = .009) ;SMD= -0.51 (95% CI: -0.87, -0.14; P = .006).
Conclusions:
Nineteen RCTs involving 4,679 participants were included. Compared with controls, digital interventions significantly reduced depressive symptoms (SMD = −0.25; 95% CI, −0.41 to −0.09; P = .002) and anxiety symptoms (SMD = −0.20; 95% CI, −0.32 to −0.08; P = .0009). Subgroup analysis by intervention duration indicated the largest effect for depressive symptoms at approximately 4 weeks (SMD = −0.26; 95% CI, −0.40 to −0.11; P = .0006). The greatest reduction in anxiety symptoms was observed at 5–8 weeks (SMD = −0.22; 95% CI, −0.47 to 0.03; P = .08), though this did not reach statistical significance.App-based interventions demonstrated the most significant effects on depression and anxiety, with effect sizes of (SMD=-0.44 (95% CI: -0.82, -0.06; P = .02) ;SMD= -0.36 (95% CI: -0.59, -0.12; P = .003), respectively. Furthermore, therapeutic efficacy was superior among the older adult population, showing values of SMD= -0.37 (95% CI: -0.64, -0.09; P = .009) ;SMD= -0.51 (95% CI: -0.87, -0.14; P = .006). Clinical Trial: CRD420251069160
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.